Tenet Healthcare Corporation (NYSE:THC) Stock Has Average Price Target of $277.25

Shares of Tenet Healthcare Corporation (NYSE:THC) have received an average recommendation of “Moderate Buy” from the twenty-one brokerages that are currently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and eighteen have issued a buy rating on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $277.25.

A number of equities research analysts have recently weighed in on the company. Leerink Partners reaffirmed an “outperform” rating and set a $309.00 price target on shares of Tenet Healthcare in a report on Friday, September 18th. Stephens restated an “overweight” rating and issued a $285.00 target price on shares of Tenet Healthcare in a research report on Monday, July 27th. TD Cowen boosted their price target on Tenet Healthcare from $233.00 to $263.00 and gave the stock a “buy” rating in a research report on Monday, July 27th. Morgan Stanley raised their price target on Tenet Healthcare from $254.00 to $274.00 and gave the company an “overweight” rating in a report on Monday, July 27th. Finally, Piper Sandler set a $308.00 price objective on shares of Tenet Healthcare in a research note on Monday, July 27th.

Tenet Healthcare Stock Performance

Shares of THC opened at $260.67 on Tuesday. The firm has a fifty day moving average of $262.89 and a 200-day moving average of $216.23. The company has a market cap of $20.99 billion, a price-to-earnings ratio of 10.05, a price-to-earnings-growth ratio of 0.99 and a beta of 1.20. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. Tenet Healthcare has a 1 year low of $157.58 and a 1 year high of $283.05.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The business had revenue of $6.04 billion for the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the company earned $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, equities analysts anticipate that Tenet Healthcare will post 21.04 earnings per share for the current year.

Insider Buying and Selling

In other news, EVP Lisa Y. Foo sold 24,000 shares of Tenet Healthcare stock in a transaction on Monday, August 31st. The stock was sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the transaction, the executive vice president directly owned 8,053 shares in the company, valued at approximately $2,144,674.96. This trade represents a 74.88% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Nadja West sold 1,152 shares of the business’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $258.80, for a total value of $298,137.60. Following the completion of the sale, the director directly owned 23,653 shares in the company, valued at $6,121,396.40. This represents a 4.64% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 131,199 shares of company stock worth $35,065,587. Company insiders own 0.97% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the business. PeakShares LLC boosted its holdings in Tenet Healthcare by 3.3% during the first quarter. PeakShares LLC now owns 1,693 shares of the company’s stock valued at $319,000 after purchasing an additional 54 shares in the last quarter. Sanctuary Advisors LLC boosted its stake in Tenet Healthcare by 0.5% in the 1st quarter. Sanctuary Advisors LLC now owns 11,900 shares of the company’s stock valued at $2,246,000 after buying an additional 57 shares in the last quarter. Applied Finance Capital Management LLC grew its position in Tenet Healthcare by 3.8% in the first quarter. Applied Finance Capital Management LLC now owns 1,644 shares of the company’s stock valued at $310,000 after acquiring an additional 60 shares during the period. Tidal Investments LLC lifted its holdings in shares of Tenet Healthcare by 0.6% during the second quarter. Tidal Investments LLC now owns 13,296 shares of the company’s stock valued at $2,487,000 after acquiring an additional 79 shares during the period. Finally, Foster & Motley Inc. boosted its stake in shares of Tenet Healthcare by 1.3% in the 1st quarter. Foster & Motley Inc. now owns 9,333 shares of the company’s stock valued at $1,761,000 after purchasing an additional 118 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation is a Dallas-based healthcare services company that operates hospitals, outpatient facilities and other healthcare businesses across the United States. Its operations include acute care hospitals, specialty hospitals, ambulatory surgery centers and related outpatient services.

Through its United Surgical Partners International subsidiary, Tenet is one of the major operators and developers of ambulatory surgery centers in the United States. These facilities provide same-day surgical procedures and other outpatient care across a range of medical specialties.